Skip to main content
. 2022 Apr 26;23(9):4764. doi: 10.3390/ijms23094764

Figure 4.

Figure 4

Main findings regarding the alterations of the ECS components in animal models and patients with schizophrenia. 2-AG: 2-arachidonoylglycerol; ACC: anterior cingulate cortex; AEA: anandamide; AMY: amygdala; CB1r: cannabinoid receptor 1; CB2r: cannabinoid receptor 2; Ctx: cortex; CSF: cerebrospinal fluid; DAGL: diacylglycerol lipase; DLPFC: dorsolateral prefrontal cortex; FAAH: fatty acid amide hydrolase; HIPP: hippocampus; HIP: hypothalamus; MAGL: monoacylglycerol lipase; NAcc: nucleus accumbens; NAPE-PLD: N-acyl phosphatidylethanolamine phospholipase; OEA: ethanolamide; PCC: posterior cingulate cortex; PFC: prefrontal cortex.